company

BioXcel Therapeutics Inc

as of 2026-07-01
Monitor thisAsk about this
at a glance
7 trials sponsored · 10 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

10 assets
BXCL501BXCL501 120 MicrogramsBXCL501 60 MicrogramsBXCL501 80 MicrogramsBXCL501 Sublingual FilmDexmedetomidineLorazepam 2 MG/MLSublingual film containing BXCL501 (Dexmedetomidine)Sublingual film containing IgalmiSublingual film containing dexmedetomidine (BXCL501)

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
BXCL501
small molecule
drug
BXCL501 120 Micrograms
small molecule
drug
BXCL501 60 Micrograms
small molecule
drug
BXCL501 80 Micrograms
small molecule
drug
BXCL501 Sublingual Film
small molecule
drug
Dexmedetomidine
small molecule
drug
Lorazepam 2 MG/ML
small molecule
drug
Sublingual film containing BXCL501 (Dexmedetomidine)
small molecule
drug